PDOs from both samples harbored a deleterious point mutation on PIK3CA gene (E545K), commonly observed in BLCa and resulting in the expression of a constitutively active PI3K25 (Fig. 6g). This evidence concerns the gene PIK3CA and bladder transitional cell carcinoma.